Related Experiment Video
Updated: Jan 9, 2026

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
Published on: July 4, 2007
A call for congressional action: revisiting the U.S. coordinated framework for the regulation of biotechnology
Leah Buchman1,2, Emma Kovak3
1Novonesis A/S, Washington, DC, United States.
Abstract:
Since the 1986 release of the Coordinated Framework for the Regulation of Biotechnology almost 40 years ago, there have been two whole of government updates that made only minor changes, while new regulations and guidance from individual agencies have made more substantial alterations. Despite scientific advances and the emergence of products that fall outside the purview of legacy statutes, repeated calls for substantive changes have gone largely unanswered. We expand upon the NSCEB's most important recommendations for improvements to the Coordinated Framework. We recommend that Congress create an NBCO and direct it to create a centralized application submission portal; conduct horizon scanning for future products of biotechnology; streamline regulations for familiar products and exempt low-risk products; and improve organizational structure, staff training, and interagency exchange.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Global Regulatory Systems
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Cooperative Binding of Transcription Regulators

